Background: Modified ultra filtration (MUF) has become widely used in pediatric cardiac surgery. MUF is capable to remove large amounts of fluid with significant improvement in the post-cardiopulmonary bypass status and laboratory parameters of the patients. There is; however; contradicting reports in the overall clinical outcome benefit following MUF. Methods: Thirty patients weighing less than 15 kg and their median age was 10 months. Undergoing open-heart surgery over a one year period was randomized to either MUF group or conventional ultrafiltration group (CUF). Parameters of investigations included perioperative laboratory findings, hemodynamic status, and duration of hospitalization, and morbidity and mortality rates. The volume of fluid removed with each method was standardized as a percentage of effective fluid balance. Results: There was no significant difference between both groups in age, weight, or duration of cardiopulmonary bypass. MUF patients group received less volume than the CUF group (175 + 72 vs. 196 + 111 ml/kg; p =0.05). There was no difference in the percentage of effective fluid balance that was removed in both groups. The MUF group showed significant higher post-cardiopulmonary bypass hematocrit levels and higher mean arterial blood pressure. Moreover, a significant reduction in chest tube drainage (27 + 16 vs 36 + 11 ml/kg p <0.001) was noted in this group. However, no difference was detected between both groups as regard duration on ventilator, number of days at ICU or at hospital. Conclusion: MUF seems to produce temporary improvement in the immediate post cardiopulmonary bypass period. However; its long term effects is similar CUF.
| Published in | International Journal of Cardiovascular and Thoracic Surgery (Volume 1, Issue 1) |
| DOI | 10.11648/j.ijcts.20150101.14 |
| Page(s) | 13-19 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Cardiopulmonary Bypass, CUF, MUF
| [1] | Maehara T, Novak I, Wyse RKH, Elliott MJ. Perioperative monitoring of total body water by bioelectrical impedance in children undergoing open-heart surgery. Eur J Cardiothorac Surg 1991; 5: 258-65. |
| [2] | Butler J, Pillai R, Rocker GM, Westaby S, Parker D, Shale DJ. Effects of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 1993; 105: 25-30. |
| [3] | Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliott M. Interleukin-8 release and neutrophil degeneration after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 105: 234-41. |
| [4] | Kopman EA, Ferguson TB. Pulmonary edema following cardiopulmonary bypass. Anesth Analg 1978; 57: 367-70. |
| [5] | Laks H, Standeven J, Blair O, Hann J, Jellinek M, Willman VL. The effects of cardiopulmonary bypass with crystelloid and colloid hemodilution on myocardial extravascular water. J Thorac Cardiovasc Surg 1977; 73: 129-34. |
| [6] | Hashimoto K, Miyamoto H, Suzuki K. Evidence of organ damage after cardiopulmonary bypass. J Torac Cardiovasc Surg 1993; 104: 666-73. |
| [7] | Donnely S, MacGrefor I, Zamani A. Plasma elastase levels and the development of adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151: 1428-33. |
| [8] | Hopkins RA, Bull C, Haworth SG, de Leval MR, Stark J. Pulmonary hypertensive crises during cardiac surgery for congenital heart defects in young children. Eur J Cardiothorac Surg 1991; 5: 628-34. |
| [9] | Bando K, Turrentine MW, Sharp TG, Sekine Y, Aufuero TX, Sun K. Pulmonary hypertension after operation for congenital heart disease: analysis of risk factor and management. J Thorac Cardiovasc Surg 1996; 112: 1600-9. |
| [10] | Yanagisawa M, Kurihard H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y. A novel potent vasoconstrictor peptide produced by vascular endolthelial cells. Nature 1998; 332: 411-5. |
| [11] | Komai H, Adatia IT, Elliot MJ, de Leval MR, Haworth SG. Increased plasma levels of endolthelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart surgery disease. J Thorac Cardiovasc Surgery 1993; 106: 473-8. |
| [12] | Bando K, Vijayaraghavan P, Turrentine MW, Sharp TG, Morelock RJ, Brown JW. Dynamic changes of endothelin-1, nitric oxide and cyclic GMP in patients with congenital heart disease. Circulation 1997; 96: II346-51. |
| [13] | Elliott MJ. Ultrafiltration and modified ultrafiltration in pediatric open-heart operations. Ann Thorac Surg 1993; 56: 1518-22. |
| [14] | Naik SK, Knight A, Elliott MJ. A successful modification of ultrafiltration for cardiopulmonary bypass in children. Perfusion 1991; 6: 41-50. |
| [15] | Ungerleider RM. Effects of cardiopulmonary bypass and use of modified ultrafiltration. Ann Thorac Surg 1998; 65: S 35-39. |
| [16] | Keenan HT, Thiagarajan R, Stephens WE, Williams G, Ramamoorthy C, Lupinetti FM. Pulmonary function after modified venous ultrafiltration in infants: a prospective randomized trial. J Thorac Cardiovasc Surg 2000; 119: 501-7. |
| [17] | Wang MJ, Chiu IS, Hsu CM, Wang CM, Lin PL, Chang CI, Huang CH, Chu SH. Efficacy of ultrafiltration in removing inflammatory mediators during pediatric operations. Ann Thorac Surg 1996; 61: 651-6. |
| [18] | Pearl JM, Manning PB, McNamara JL, Saucier MM, Thomas DW. Effects of modified ultrafiltration on plasma Thromboxane B2, Leukotrine B4, and Endothelin-1 in infants undergoing cardiopulmonary bypass. 1999; 68: 1369-1375. |
| [19] | Thompson LD, McElhinney DB, Findlay P, Miller-Hance W, Chen MJ, Minami M, Petrossian E, Parry AJ, Redddy VM, Hanley FL. A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2001; 122: 220-8. |
| [20] | Koutlas TC, Gaynor JW, Nicolson SC, Steven JM Wemovsky G, Spray TL. Modified ultrafiltration reduces post-operative morbidity after cavopulmonary connection. Ann Thorac Surg 1997; 64: 37- 43. |
| [21] | Yokoyama K, Takabayashi S, Komada T, Onoda K, Mitani Y, Iwata H, Shimpo H. Removal of prostaglandin E2 and increased intraoperative blood pressure during modified ultrafiltration in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2009; 137: 730-5. |
| [22] | Bando K, Turrentine MW, Vijay P, Sharp TG, Sekine Y, Lalone BJ, Szekely L, Brown JW. Effects of modified ultra-filtration in high risk patients undergoing operations for congenital heart disease. Ann Thorac Surg 1998; 66: 823-8. |
| [23] | Draaisma AM, Hazenkamp MG, Frank M, Anes N, Schoof PH, Huysmans HA. Modified ultra-filtration after cardiopulmonary bypass in pediatric cardiac surgery. Ann Thorac Surg 1997; 64: 521-5. |
| [24] | Bando K, Vijay P, Turrentime MW, Sharp TG, Means LJ, Ensing GJ, Lalone BJ, Sekine Y, Szekely L, Brown JW. Dilutional and modified ultra-filtration reduces pulmonary hypertension after operations for congenital heart disease: a prospective randomized study. J Thorac Cardiovasc Surg 1998; 115: 17-27. |
| [25] | Kuratani N, Bunsangjaroen P, Srimueang T, Masaki E, Suzuki T, Katogi T. Modified versus conventional ultrafiltration in pediatric cardiac surgery: A meta-analysis of randomized controlled trials comparing clinical outcome parameters. J Thorac Cardiovasc Surg 2011; 142: 861-7. |
| [26] | Davies MJ, Nguyen K, Gaynor JW, Elliott MJ. Modified ultra-filtration improves left ventricular systolic function in infants after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1998; 115: 361-70. |
| [27] | Chaturvedi RR, Shore DF, White PA, Scallan MH, Gothard WW, Reddington AN, Lincoln C. Modified ultra-filtration improves global left ventricular systolic function after open heart surgery in infants and children. Eur J Cardiothorac Surg 1999; 15: 742 - 6. |
| [28] | Hodges UM, Berg S, Naik SK, Bower S, Lloyd-Thomas A, Elliott M. Filtration of fentanyl is not the cause of the elevation of arterial blood pressure associated with post-bypass ultrafiltration in children. J Cardiothorac Vasc Anesth 1994; 8: 653 -7. |
| [29] | Ootaki Y, Yamaguchi M, Oshima Y, Yoshimura N, Oka S. Effects of modified ultrafiltration on coagulation factors in pediatric cardiac surgery. Surg Today 2002; 32: 203-6. |
| [30] | McEwan A. Aspects of bleeding after cardiac surgery in children. Pediatr anesth 2007; 17: 1126-33. |
| [31] | Mahmoud AB, Burhani MS, Hannef AA, Jamjoom AA, Al-Githmi IS, Baslaim GM. Effect of modified ultrafiltration on pulmonary function after cardiopulmonary bypass. Chest 2005; 128: 3447-53. |
| [32] | Allan CK, Newburger JW, McGArth E, Elder J, Psoinos C, Laussen PC. The relationship between inflammatory activation and clinical outcome after infant cardiopulmonary bypass. Anesth Analg 2010; 111: 1244-51. |
APA Style
Akram Allam, Wael Hassanein, Walid Abu Arab, Ahmed Othman, Mohsen AbdelAzeem. (2015). Does Modified Ultra Filtration Affect Clinical Outcome Following Pediatric Cardiac Surgery. International Journal of Cardiovascular and Thoracic Surgery, 1(1), 13-19. https://doi.org/10.11648/j.ijcts.20150101.14
ACS Style
Akram Allam; Wael Hassanein; Walid Abu Arab; Ahmed Othman; Mohsen AbdelAzeem. Does Modified Ultra Filtration Affect Clinical Outcome Following Pediatric Cardiac Surgery. Int. J. Cardiovasc. Thorac. Surg. 2015, 1(1), 13-19. doi: 10.11648/j.ijcts.20150101.14
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijcts.20150101.14,
author = {Akram Allam and Wael Hassanein and Walid Abu Arab and Ahmed Othman and Mohsen AbdelAzeem},
title = {Does Modified Ultra Filtration Affect Clinical Outcome Following Pediatric Cardiac Surgery},
journal = {International Journal of Cardiovascular and Thoracic Surgery},
volume = {1},
number = {1},
pages = {13-19},
doi = {10.11648/j.ijcts.20150101.14},
url = {https://doi.org/10.11648/j.ijcts.20150101.14},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcts.20150101.14},
abstract = {Background: Modified ultra filtration (MUF) has become widely used in pediatric cardiac surgery. MUF is capable to remove large amounts of fluid with significant improvement in the post-cardiopulmonary bypass status and laboratory parameters of the patients. There is; however; contradicting reports in the overall clinical outcome benefit following MUF. Methods: Thirty patients weighing less than 15 kg and their median age was 10 months. Undergoing open-heart surgery over a one year period was randomized to either MUF group or conventional ultrafiltration group (CUF). Parameters of investigations included perioperative laboratory findings, hemodynamic status, and duration of hospitalization, and morbidity and mortality rates. The volume of fluid removed with each method was standardized as a percentage of effective fluid balance. Results: There was no significant difference between both groups in age, weight, or duration of cardiopulmonary bypass. MUF patients group received less volume than the CUF group (175 + 72 vs. 196 + 111 ml/kg; p =0.05). There was no difference in the percentage of effective fluid balance that was removed in both groups. The MUF group showed significant higher post-cardiopulmonary bypass hematocrit levels and higher mean arterial blood pressure. Moreover, a significant reduction in chest tube drainage (27 + 16 vs 36 + 11 ml/kg p <0.001) was noted in this group. However, no difference was detected between both groups as regard duration on ventilator, number of days at ICU or at hospital. Conclusion: MUF seems to produce temporary improvement in the immediate post cardiopulmonary bypass period. However; its long term effects is similar CUF.},
year = {2015}
}
TY - JOUR T1 - Does Modified Ultra Filtration Affect Clinical Outcome Following Pediatric Cardiac Surgery AU - Akram Allam AU - Wael Hassanein AU - Walid Abu Arab AU - Ahmed Othman AU - Mohsen AbdelAzeem Y1 - 2015/07/01 PY - 2015 N1 - https://doi.org/10.11648/j.ijcts.20150101.14 DO - 10.11648/j.ijcts.20150101.14 T2 - International Journal of Cardiovascular and Thoracic Surgery JF - International Journal of Cardiovascular and Thoracic Surgery JO - International Journal of Cardiovascular and Thoracic Surgery SP - 13 EP - 19 PB - Science Publishing Group SN - 2575-4882 UR - https://doi.org/10.11648/j.ijcts.20150101.14 AB - Background: Modified ultra filtration (MUF) has become widely used in pediatric cardiac surgery. MUF is capable to remove large amounts of fluid with significant improvement in the post-cardiopulmonary bypass status and laboratory parameters of the patients. There is; however; contradicting reports in the overall clinical outcome benefit following MUF. Methods: Thirty patients weighing less than 15 kg and their median age was 10 months. Undergoing open-heart surgery over a one year period was randomized to either MUF group or conventional ultrafiltration group (CUF). Parameters of investigations included perioperative laboratory findings, hemodynamic status, and duration of hospitalization, and morbidity and mortality rates. The volume of fluid removed with each method was standardized as a percentage of effective fluid balance. Results: There was no significant difference between both groups in age, weight, or duration of cardiopulmonary bypass. MUF patients group received less volume than the CUF group (175 + 72 vs. 196 + 111 ml/kg; p =0.05). There was no difference in the percentage of effective fluid balance that was removed in both groups. The MUF group showed significant higher post-cardiopulmonary bypass hematocrit levels and higher mean arterial blood pressure. Moreover, a significant reduction in chest tube drainage (27 + 16 vs 36 + 11 ml/kg p <0.001) was noted in this group. However, no difference was detected between both groups as regard duration on ventilator, number of days at ICU or at hospital. Conclusion: MUF seems to produce temporary improvement in the immediate post cardiopulmonary bypass period. However; its long term effects is similar CUF. VL - 1 IS - 1 ER -
Information
Email: